DE602006016576D1 - Strahlentherapieverstärker - Google Patents

Strahlentherapieverstärker

Info

Publication number
DE602006016576D1
DE602006016576D1 DE602006016576T DE602006016576T DE602006016576D1 DE 602006016576 D1 DE602006016576 D1 DE 602006016576D1 DE 602006016576 T DE602006016576 T DE 602006016576T DE 602006016576 T DE602006016576 T DE 602006016576T DE 602006016576 D1 DE602006016576 D1 DE 602006016576D1
Authority
DE
Germany
Prior art keywords
radiation amplifier
amplifier
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006016576T
Other languages
English (en)
Inventor
Masakazu Fukushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE602006016576D1 publication Critical patent/DE602006016576D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602006016576T 2005-04-01 2006-03-31 Strahlentherapieverstärker Active DE602006016576D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005105819 2005-04-01
PCT/JP2006/306959 WO2006106983A1 (ja) 2005-04-01 2006-03-31 放射線治療増強剤

Publications (1)

Publication Number Publication Date
DE602006016576D1 true DE602006016576D1 (de) 2010-10-14

Family

ID=37073533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006016576T Active DE602006016576D1 (de) 2005-04-01 2006-03-31 Strahlentherapieverstärker

Country Status (12)

Country Link
US (3) US20080275071A1 (de)
EP (1) EP1864683B1 (de)
JP (1) JP4956423B2 (de)
KR (1) KR101065932B1 (de)
CN (2) CN101912399B (de)
AU (1) AU2006231808B2 (de)
CA (1) CA2603809C (de)
DE (1) DE602006016576D1 (de)
ES (1) ES2348996T3 (de)
HK (2) HK1118704A1 (de)
TW (1) TWI434700B (de)
WO (1) WO2006106983A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI371447B (en) * 2005-04-01 2012-09-01 Taiho Pharmaceutical Co Ltd Radiotherapy enhancer having a pyridine derivative as an active ingredient
TWI488659B (zh) * 2011-05-25 2015-06-21 Taiho Pharmaceutical Co Ltd Containing tegafur, gemcitabine, and otiracazide
US9877966B1 (en) * 2015-08-10 2018-01-30 Eugene J. Oliva Combination therapy for the inhibition of metastasis and tumorigenesis
CN106692173A (zh) * 2015-11-18 2017-05-24 北京诺普德医药科技有限公司 一种抗肿瘤复方组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62155215A (ja) 1984-11-30 1987-07-10 Otsuka Pharmaceut Co Ltd 抗腫瘍活性増強剤
KR0148589B1 (ko) * 1991-05-27 1998-11-02 고바야시 유끼오 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
WO2003004640A1 (fr) * 2001-07-05 2003-01-16 Taiho Pharmaceutical Co., Ltd. Reseaux d'adn permettant de mesurer la sensibilite a un agent anticancereux
ATE408408T1 (de) * 2003-03-14 2008-10-15 Taiho Pharmaceutical Co Ltd Eine die antitumorwirkung verstärkende verbindung und antitumormittel
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
US8198264B2 (en) * 2006-04-28 2012-06-12 National Cancer Center Method for treating head and neck cancer

Also Published As

Publication number Publication date
CA2603809C (en) 2011-12-06
HK1118704A1 (en) 2009-02-20
CA2603809A1 (en) 2006-10-12
US20130101680A1 (en) 2013-04-25
EP1864683A4 (de) 2008-12-24
KR101065932B1 (ko) 2011-09-19
TW200716180A (en) 2007-05-01
CN101912399A (zh) 2010-12-15
CN101155600B (zh) 2011-05-04
CN101155600A (zh) 2008-04-02
KR20080000628A (ko) 2008-01-02
AU2006231808B2 (en) 2010-06-24
WO2006106983A1 (ja) 2006-10-12
JPWO2006106983A1 (ja) 2008-09-25
EP1864683B1 (de) 2010-09-01
EP1864683A1 (de) 2007-12-12
US20090281105A1 (en) 2009-11-12
HK1148204A1 (en) 2011-09-02
CN101912399B (zh) 2012-05-23
US20080275071A1 (en) 2008-11-06
ES2348996T3 (es) 2010-12-21
TWI434700B (zh) 2014-04-21
AU2006231808A1 (en) 2006-10-12
JP4956423B2 (ja) 2012-06-20

Similar Documents

Publication Publication Date Title
DE602006020996D1 (de) Hreren eingängen
ATE408603T1 (de) Pyrazolylcarboxanilide
DE602006016378D1 (de) Extrem-UV-Strahlungsquelle
CR9974A (es) Gavión
DE502006003394D1 (de) Lehnenklappung
DE502006008475D1 (de) Wasserpumpenflügelrad
DE602006010503D1 (de) Optischer Verstärker
DE602006009573D1 (de) Vorspannungsschaltung
DE502006005667D1 (de) Gelenklager
ATE549324T1 (de) Tetrahydrobenzoxazine
DE502006005768D1 (de) Hydrolysestabilisatorformulierungen
DE502006006857D1 (de) Wingungserregern
DE112006002964A5 (de) Zweirichtungsreflektanzverteilungsmessgerät
DE502005005839D1 (de) Feldgeerät
DE502006001397D1 (de) Lagerbuchse
DE602006000131D1 (de) Bandauswahl-Vorwärtskopplungsverstärker
DE602004031602D1 (de) Vorverstärker
ATE485368T1 (de) Hiv - impfung
ITMI20051422A1 (it) Struttura di amplificatore raman
DE502006004302D1 (de) Verschlusskappe
DE502006003147D1 (de) Verbundgußplatte
DE502006001004D1 (de) Hydrolager
DE102005052834B8 (de) Punktschweißklebverbindung
DE602006016576D1 (de) Strahlentherapieverstärker
DE502006003210D1 (de) Nohydrogenpolysiloxanen